Breaking News

Clearmind Medicine Partners with IMP for Upcoming Clinical Trial

IMP will be responsible for the global clinical supply chain of Clearmind’s candidate CMND-100 from manufacture to the various clinical sites.

Clearmind Medicine Inc., a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, entered an agreement with IMP Clinical Supply Services (IMP). IMP will be responsible for the global clinical supply chain of Clearmind’s proprietary drug candidate CMND-100 from manufacture to the various clinical sites. IMP is known for its comprehensive, tailor-made clinical supply services that address all study requirement...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters